The World Health Organization has validated Australia for eliminating trachoma as a public health problem, marking a major milestone in both national and global health efforts. Trachoma, caused by the bacterium Chlamydia trachomatis, is the leading infectious cause of blindness worldwide, spreading through close contact, contaminated surfaces, and flies. Its elimination in Australia reflects significant progress toward global targets set under the WHO roadmap for neglected tropical diseases (NTDs) 2021–2030.
Australia’s success is the result of decades of sustained public health efforts, particularly in remote Aboriginal and Torres Strait Islander communities where the disease had persisted. The establishment of the National Trachoma Management Programme in 2006 played a crucial role, implementing the WHO-recommended SAFE strategy, which combines surgery, antibiotics, facial cleanliness, and environmental improvements. Regular screening and targeted interventions, supported by partnerships between governments, community-controlled health organizations, and local communities, contributed to a steady decline in infection rates.
Key to this achievement was a community-centered approach that addressed broader determinants of health, including improvements in housing, water, sanitation, and hygiene. Australia also adapted its strategy to local conditions by using targeted treatments based on community data rather than relying solely on mass drug administration. Leadership from Aboriginal and Torres Strait Islander communities and culturally appropriate healthcare delivery were central to the program’s success.
Trachoma is one of several diseases classified as neglected tropical diseases, which affect over a billion people globally, mainly in underserved populations. Australia’s elimination of trachoma demonstrates that even in geographically challenging settings, sustained political commitment, adequate resources, and cross-sector collaboration can lead to success. This marks the first time the WHO has confirmed the elimination of an NTD in Australia, making it one of the countries contributing to global progress in this area.
The achievement also highlights the importance of maintaining vigilance to sustain progress. Continued surveillance, integration into national health systems, and ongoing support from global health partners remain essential to prevent re-emergence. The WHO continues to assist countries worldwide in eliminating trachoma and other NTDs, ensuring that health gains reach the most vulnerable populations and are maintained over time.
